(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 2.8% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.21%.
Qiagen Nv's revenue in 2023 is $2,225,932,000.On average, 4 Wall Street analysts forecast QGEN's revenue for 2023 to be $473,136,691,500, with the lowest QGEN revenue forecast at $458,906,580,000, and the highest QGEN revenue forecast at $481,835,970,000. On average, 2 Wall Street analysts forecast QGEN's revenue for 2024 to be $511,309,458,000, with the lowest QGEN revenue forecast at $509,565,276,000, and the highest QGEN revenue forecast at $513,053,640,000.
In 2025, QGEN is forecast to generate $551,238,930,000 in revenue, with the lowest revenue forecast at $551,238,930,000 and the highest revenue forecast at $551,238,930,000.